Clinical Trials

A Phase I Study of Sterotactic Body Radiotherapy (SBRT)for the Treatment of Multiple Metastases


Study ID
NRG Oncology BR001

NCT Number
NCT02206334 (Click on the NCT number for more information about the trial)

Research Study Number
2017-0194

Principle Investigator
Dr. Brett Lewis

Phase
I

Sponsor
NRG Oncology


Other protocol defined inclusion/exclusion criteria could apply If you are a physician and would like more details about this study, please contact us at JTCCResearch@HackensackMeridian.org

Apply Now